Infection
Symposium
Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Aims : To review the results of the latest bronchiectasis clinical trials, compare the pros and cons of oral and inhaled antibiotic therapies in bronchiectasis, describe the emerging scientific techniques that are used to study the airway microbiome and monitor airway inflammation in bronchiectasis, review the evidence for physiotherapy management and emerging airway clearance devices and therapies and describe the activities of the European bronchiectasis network and the opportunities to participate.
14:45
Understanding the heterogeneity of the disease
S. Aliberti(Milano (MI), Italy)
COI
1
2879
15:15
Oral vs. inhaled antibiotic therapy
S. Elborn(Belfast (Belfast), United Kingdom)
COI
2
2880
15:45
Airway clearance techniques in bronchiectasis
E. Polverino(Barcelona, Spain)
COI
3
2881
16:15
The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network
J. Chalmers(Dundee (Angus), United Kingdom)
COI
4
2882
. . .